Browse by author
Lookup NU author(s): Dr Paul Benneworth
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Conceptions of innovation in the biotechnology industry are rooted in the belief that biotechnology is part of the commercialisation of science in support of pharmaceutical R&D. The consequence of this has been to make two assumptions: that all biotechnology innovation is high science-content, and that only high science-content innovation is worth pursuing. This suggests that the future geography of biotechnology innovation will be limited to those locations with existing biotechnology research assets. This paper looks at one region in which there are no high science-content biotechnology R&D assets and finds that despite this situation, biotechnology innovation is still present. That innovation is characterised as low science-content innovation (LSC1), and the argument is developed that this mode of innovation is also present in more successful regions. The paper concludes that there is a need for biotechnology innovation studies in more successful regions to deal with the issue of LSC1, whilst beginning to explore the kinds of technological infrastructure necessary for the support of LSC1.
Author(s): Benneworth P
Publication type: Article
Publication status: Published
Journal: International Journal of Biotechnology
ISSN (print): 0963-6048
ISSN (electronic): 1741-5020
Publisher: Inderscience Publishers
Altmetrics provided by Altmetric